Regeneron (REGN) Halted Ahead of FDA Panel Review of Praluent

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. ABBV
2. MU
3. SPCX
4. IBM
5. ACN
6. NVDA
7. PRIM
8. META
9. SPY
10. TSLA

Go back to Regeneron (REGN) Halted Ahead of FDA Panel Review of Praluent
Regeneron (NASDAQ: REGN) Delayed: 614.79 +2.29 (0.37%)
Previous Close $612.50    52 Week High $592.36 
Open $607.92    52 Week Low $325.35 
Day High $621.79    P/E 161.36 
Day Low $607.92    EPS $3.81 
Volume 235,622